TITLE

Pleural Effusion and Breast Cancer

AUTHOR(S)
Porter, E. H.
PUB. DATE
January 1965
SOURCE
British Medical Journal;1/23/1965, Vol. 1 Issue 5429, p251
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64057371

 

Related Articles

  • Catumaxomab.  // Reactions Weekly;1/28/2012, Issue 1386, p14 

    The article describes the case of a 53-year-old woman with breast cancer and a 68-year-old man with lung cancer who developed various toxicities following two doses of catumaxomab for malignant pleural effusion.

  • Malignant Pleural Effusion. Shuey, Kathleen; Payne, Yvette; Burke, Catherine // Clinical Journal of Oncology Nursing;Oct2005, Vol. 9 Issue 5, p529 

    Provides information on malignant pleural effusion (MPE), a disease caused by direct tumor involvement of the pleural space by solid or hematologic malignancies. Types of cancer associated with 75 percent of MPE; Symptoms associated with pleural effusion; Diagnosis and treatment.

  • Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis. Miyoshi, Shion; Sasada, Shinji; Izumo, Takehiro; Matsumoto, Yuji; Tsuchida, Takaaki // PLoS ONE;11/23/2016, Vol. 11 Issue 11, p1 

    Background: Some trials recently demonstrated the benefit of targeted treatment for malignant disease; therefore, adequate tissues are needed to detect the targeted gene. Pleural biopsy using flex-rigid pleuroscopy and pleural effusion cell block analysis are both useful for diagnosis of...

  • Fatores clínicos e anatomopatológicos que influenciam a sobrevida de pacientes com câncer de mama e derrame pleural neoplásico. Tavares dos Santos, Giovana; Carlos Prolla, João; Dressler Camillo, Natália; Silveira Zavalhia, Lisiane; Ranzi, Alana Durayski; Giuliano Bica, Claudia // Jornal Brasileiro de Pneumologia;jul/aug2012, Vol. 38 Issue 4, p487 

    Objective: The objective of this study was to identify the clinical and pathological factors that can influence the prognosis of breast cancer patients with clinical symptoms of malignant pleural effusion. Methods: This was a clinical cohort study, in which we analyzed the medical charts of...

  • Primary Effusion Lymphoma In A Non-HIV Patient: A Case Report And Discussion Of Treatment Modalities. Heidecker, Jay T.; Strange, Charlie // Internet Journal of Pulmonary Medicine;2004, Vol. 4 Issue 2, p29 

    Pleural effusion is a rare initial presentation of lymphoma. There is a subset of lymphoma based in serosal surfaces that is almost universally associated with advanced HIV infection. We describe a case of primary pleural SCLL that proved refractory to pleuridesis. With initiation of...

  • Use of the Pleurx® Pleural Catheter for the Management of Malignant Pleural Effusions. Brubacher, Sara; Gobel, Barbara Holmes // Clinical Journal of Oncology Nursing;Jan/Feb2003, Vol. 7 Issue 1, p1 

    Many patients with cancer, especially those with lung and breast cancer, experience malignant pleural effusions. Several treatment options exist, and most require hospitalization. The Pleurx® Pleural Catheter (Denver Biomedical, Golden, CO) is a new treatment option that allows patients to be...

  • Purified talc.  // Reactions Weekly;1/31/2009, Issue 1237, p20 

    The article describes the case of a 39-year-old woman who developed interstitial pneumonitis with respiratory failure following talc pleurodesis. The patient, who had a history of breast cancer, underwent talc pleurodesis for a recurrent, symptomatic left pleural effusion. Time to reaction onset...

  • Effect of IL-6 Elevation in Malignant Pleural Effusion on Hyperfibrinogenemia in Lung Cancer Patients. Yamaguchi, Toshihiko; Kimura, Hiromi; Yokota, Soichiro; Yamamoto, Yuko; Hashimoto, Taikichi; Nakagawa, Masaru; Ito, Masami; Ogura, Takeshi // Japanese Journal of Clinical Oncology;Feb2000, Vol. 30 Issue 2 

    Investigates the effect of interleukin-6 (IL-6) elevation in malignant pleural effusion on hyperfibrinogenemia in lung cancer patients. Measurements of IL-6 and tumor necrosis factor-alpha in serum and pleural effusion; Immunohistochemical detection of IL-6 in pleural cells; Systemic leakage of...

  • Clinico- pathological profile and course of malignant pleural effusion in a tertiary care teaching hospital in western U.P. with special reference to lung cancer. Agrawal, Anurag; Tandon, Rajeev; Singh, Lalit; Chawla, Aakanksha // Lung India;Jul/Aug2015, Vol. 32 Issue 4, p326 

    Background: Malignant pleural effusion is a major clinical problem associated with primary and metastatic pleural malignancies. Pleural effusions from an unknown primary are responsible for 7-15% of all malignant pleural effusions. Presence of malignant pleural effusion puts the patient in...

  • MCF-7 Cells--Changing the Course of Breast Cancer Research and Care for 45 Years. Lee, Adrian V.; Oesterreich, Stefi; Davidson, Nancy E. // JNCI: Journal of the National Cancer Institute;7/15/2015, Vol. 107 Issue 7, p1 

    It is 45 years since a pleural effusion from a patient with metastatic breast cancer led to the generation of the MCF-7 breast cancer cell line. MCF-7 is the most studied human breast cancer cell line in the world, and results from this cell line have had a fundamental impact upon breast cancer...

Share

Read the Article

Other Topics